• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. XENOSURE BIOLOGICAL PATCH; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. XENOSURE BIOLOGICAL PATCH; MESH, SURGICAL Back to Search Results
Catalog Number E0.8P8
Device Problem Material Rupture (1546)
Patient Problem Tissue Damage (2104)
Event Date 07/01/2016
Event Type  malfunction  
Manufacturer Narrative
Through communication with the physician we were able to learn that the fogarty catheter was about 1/3 inflated upon removal through the patch.Additionally, the user was removing clot material from the vessel, thereby increasing surface area of material that was passing through the graftotomy along with the expanded balloon.It is likely that this excess material led to strain on the graftotomy area and created a tear.Our device tracing system was able to determine that the user had also implanted several other patches from this same lot without any reported issues.Our lot history review did not discover any issues related to the manufacturing or packaging of this lot.Our investigation, including consultation with our medical director, concluded that this issue was likely due to operator influence and that the device was not likely the cause of the issue.The report was initially submitted on 02aug2016 through mail.However, on 8/16/2016 we received letter from fda to submit the form electronically.
 
Event Description
The customer reported that during a femoral endarterectomy procedure with patching, the device experienced a transverse tear.The physician intervened by performing a graftotomy ( cutting of the patch ) and passing of a 4f fogarty catheter to clear the obstructions both proximally and distally to the graft site.After passing the fogarty repeatedly thought the graftotomy site, the patch experienced a transverse tear to the suture line.Doctor removed patch and discarded, replaced with another patch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XENOSURE BIOLOGICAL PATCH
Type of Device
MESH, SURGICAL
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer Contact
pragya thikey
63 second ave
burlington, MA 01803
7812212266
MDR Report Key5886684
MDR Text Key53446151
Report Number1220948-2016-00014
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K040835
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial
Report Date 08/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date01/28/2019
Device Catalogue NumberE0.8P8
Device Lot NumberXBU1605
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-